EDAP TMS S.A. (EDAP)

NGM – Real vaqt narxi. Valyuta: USD

4.08

-0.09 (-2.16%)

Yopilishda: May 12, 2026, 4:00 PM EDT

07.05.2026

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

07.05.2026

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

, May 07, 2026 (GLOBE NEWSWIRE) -- EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

30.04.2026

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

, April 30, 2026 (GLOBE NEWSWIRE) -- EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate Cancer

16.04.2026

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

, April 16, 2026 (GLOBE NEWSWIRE) -- EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 Company to host conference call and webcast on Thursday, May 7 at 8:30 a.m. EDT AUSTIN, Texas, April 16, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March 31, 2026, before market open on Thursday, May 7, 2026.

25.03.2026

EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript

25.03.2026

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue 39% Full-Year YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in the Number of U.S. Focal One Procedures 69% Full-Year YoY Growth in Focal One System Placements 28% Q4 YoY Growth in U.S. Procedures, Marking the Second Consecutive Quarter of Double-Digit Procedure Growth Demand for Focal One Systems Remains Strong with System Placements in Academic Cancer Centers, Community Hospitals, and Large Integrated Healthcare Networks Company Reiterates its Previously Issued 2026 Revenue Guidance; HIFU Revenue Expected to Grow Between 34% and 45% YoY AUSTIN, Texas, March 25, 2026 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today financial results for the fourth quarter and full-year 2025. “We experienced strong global demand for Focal One Robotic HIFU as demonstrated by our 2025 results,” said Ryan Rhodes, Chief Executive Officer.

10.03.2026

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Company to Present and Host 1x1 Investor Meetings on Wednesday, March 18 th , 2026 AUSTIN, Texas, March 10, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and, together with Ken Mobeck, Chief Financial Officer, will host 1x1 investor meetings at the upcoming Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Date: Wednesday, March 18th Time: 12:00-12:30 PM ET Format: Virtual Presentation and 1x1 investor meetings Webcast:https://event.summitcast.com/view/2MZVg3DCx8a3zxe3mMMekq/6YGp8gAgsNuJhACXjn75JB The live and archived webcast of the presentation can be accessed in the Investors section of the Company's website here.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

, May 07, 2026 (GLOBE NEWSWIRE) -- EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

30.04.2026

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

, April 30, 2026 (GLOBE NEWSWIRE) -- EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate Cancer

25.03.2026

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

12.02.2026

EDAP Announces Appointment of David Horn to Board of Directors

EDAP Announces Appointment of David Horn to Board of Directors AUSTIN, Texas, February 12, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) (“the Company” or “EDAP”), a global leader in therapeutic ultrasound technology, today announced the appointment of David Horn to its Board of Directors, effective February 11, 2026.

EDAP TMS S.A. (EDAP)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

EDAP TMS S.A. (EDAP)

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Videolar

No Data

Press-relizlar

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP Announces Appointment of David Horn to Board of Directors

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Videolar

No Data

Press-relizlar

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP Announces Appointment of David Horn to Board of Directors

Search stocks

EDAP TMS S.A. (EDAP)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

EDAP TMS S.A. (EDAP)

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Videolar

No Data

Press-relizlar

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP Announces Appointment of David Horn to Board of Directors

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Videolar

No Data

Press-relizlar

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP Announces Appointment of David Horn to Board of Directors